InMed Pharmaceuticals Files 8-K
Ticker: INM · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1728328
| Field | Detail |
|---|---|
| Company | Inmed Pharmaceuticals INC. (INM) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
InMed Pharma filed an 8-K on 4/8 for events on 4/4 - check for updates.
AI Summary
InMed Pharmaceuticals Inc. filed an 8-K on April 8, 2025, reporting an event that occurred on April 4, 2025. The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as key items. The company is incorporated in British Columbia and its principal executive offices are located in Vancouver, Canada.
Why It Matters
This 8-K filing signals that InMed Pharmaceuticals Inc. has reported significant events or submitted financial statements and exhibits to the SEC, which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting event and does not contain specific financial or operational disclosures that would immediately indicate high risk.
Key Players & Entities
- InMed Pharmaceuticals Inc. (company) — Filer of the 8-K
- April 4, 2025 (date) — Date of earliest event reported
- April 8, 2025 (date) — Date of report
- Vancouver, Canada (location) — Location of principal executive offices
FAQ
What specific 'Other Events' are being reported by InMed Pharmaceuticals Inc. in this 8-K?
The filing does not detail the specific 'Other Events' beyond listing it as an item of information.
What types of 'Financial Statements and Exhibits' were filed with this 8-K?
The filing lists 'Financial Statements and Exhibits' as an item of information but does not specify their content.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 4, 2025.
What is the principal executive office address for InMed Pharmaceuticals Inc.?
The principal executive offices are located at Suite 1445 - 885 W. Georgia Street, Vancouver, B.C., Canada, V6C 3E8.
What is the SIC code for InMed Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for InMed Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding InMed Pharmaceuticals Inc. (INM).